Cue Health (Nasdaq:HLTH) and Major League Baseball (MLB) announced today that will expand on league-wide COVID-19 testing. Under a national partnership, Cue Health — MLB’s trusted at-home testing solution — will provide MLB clubs as well as the league office with its integrated care platform that includes the portable and reusable Cue Health monitoring system […]
Cue Health
Cue Health launches direct-to-consumer virtual health platform
Cue Health (NSDQ:HLTH) announced today that it will launch its direct-to-consumer virtual health program on Nov. 15, 2021. San Diego-based Cue Health’s virtual health platform includes what it says is a first-of-its kind molecular COVID-19 test through its new eCommerce site and in-app shop. The company said in a news release that it makes the […]
MedTech 100 roundup: More growth ahead?
A turgid month for the medtech industry might be drifting into the past after the past week indicated a slight turnaround as summer nears. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week at 107.74 points, marking a 1.4% rise from the 106.22-point mark set one […]
Cue Health raises $235M to support its over-the-counter, home-use diagnostics
Healthcare technology company Cue Health announced that it closed a private financing round worth $235 million. Existing investors Johnson & Johnson Innovation — JJDC, Decheng Capital, CAVU Ventures, ACME Capital and more contributed to the financing, as did new investors Perceptive Advisors, MSD Capital and Koch Strategic Platforms, according to a news release. Morgan Stanley […]
5 at-home COVID-19 diagnostic tests you should know
The wait for a completely at-home COVID-19 test ended in November when the FDA authorized the first ones that enabled people to obtain samples and results at home. The agency since then has authorized five at-home COVID-19 tests for emergency use since the beginning of the pandemic. The kits are made to take a sample […]
First OTC molecular test for COVID-19 gains FDA nod
The FDA today issued its first emergency use authorization for a molecular COVID-19 diagnostic test for at-home use without a prescription. The Cue Health COVID-19 Test for Home and Over The Counter (OTC) use is a molecular nucleic acid amplification test designed to detect genetic material from the SARS-CoV-2 virus in the nostrils. The authorized […]
MedTech 100 roundup: Industry continues its ascent
Stocks in the medtech industry maintained their upward trajectory, topping last week’s peak with yet another rise to new heights. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 95.66 (Oct. 16), marking a 0.6% gain from the 95.05 points registered at the end of […]
Cue Health lands $481M from HHS for COVID-19 test
The federal government has awarded startup Cue Health $481 million to increase domestic production capacity of point-of-care testing for COVID-19. The money from the Department of Health and Human Services and the Department of Defense will enable San Diego, Calif.-based Cue to manufacture 100,000 COVID-19 test kits per day by March 2021, including 6 million […]
